COMMUNIQUÉS West-GlobeNewswire

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
20/07/2026
REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
20/07/2026
Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Regulatory Submissions for Future Commercial Supply. Company Expresses Support for MHRA Draft Rare Disease Therapies [...]
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
20/07/2026
MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
20/07/2026
STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Nouscom Selected for Oral Presentation on NOUS-209 Re-treatment and Long-Term Follow-Up in Lynch Syndrome Carriers at ESMO Congress 2026
20/07/2026
New data from the Phase 1b/2 trial of NOUS-209 in Lynch Syndrome (LS) carriers have been accepted for an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026 NOUS-209 is an off-the-shelf [...]
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
20/07/2026
SOUTH ORANGE, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced today that President [...]
Frishantic Launches Chelated Magnesium Glycinate for Nighttime Calm and Daily Muscle Ease
20/07/2026
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Frishantic today announced the launch of Frishantic Magnesium Glycinate , a chelated magnesium glycinate supplement designed for consumers seeking nighttime relaxation support [...]
CLINUVEL’s ADS to commence trading on Nasdaq
20/07/2026
CUVL to trade on the highest tier – Global Select Market MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is [...]
Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors
20/07/2026
Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery. ZURICH, [...]
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
20/07/2026
SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced the launch of Kyinsu®, the world's first [...]
Burntide Gummies Launch 2026 | Advanced Weight Loss Formula Highlights Ingredients, Supplement Facts Available in USA, UK, CA, By BurnTide.
19/07/2026
BurnTide Announcing updated ingredient information, supplement facts, usage guidance, and customer support details, giving consumers a complete overview before choosing the Weight Loss Gummies Formula. New York City, [...]
ColestZen Official Launch 2026 | Cholesterol Support Capsules Available in USA, UK, CA & AU Market By Colestzen Supplement.
18/07/2026
ColestZen Official Store announces ColestZen Supplement, formulated with carefully selected ingredients to support healthy cholesterol, support healthy blood sugar levels already within the normal range, and promote [...]
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
18/07/2026
After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerated with no new [...]
2,300+ cyclists pedal to a record-breaking $12.5M for Alberta cancer care
18/07/2026
After years of riding for the people she loved, recently diagnosed breast cancer patient Heidi Panych returns to the road to share her own story. STRATHMORE, July 18, 2026 (GLOBE NEWSWIRE) -- Three years ago, when Heidi [...]
La Society for Medical Decision Making décerne le 2026 Career Achievement Award à Uwe Siebert, professeur à Harvard et à UMIT TIROL
18/07/2026
OSLO, Norvège, 18 juill. 2026 (GLOBE NEWSWIRE) -- La Society for Medical Decision Making (SMDM) a remis sa distinction professionnelle la plus prestigieuse, le 2026 Career Achievement Award , au professeur Uwe Siebert, [...]
Vireo Growth Inc. Completes Acquisition of Pennsylvania Dispensary License Transaction
18/07/2026
MINNEAPOLIS, July 17, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that it has completed its previously announced acquisition of all of the issued and [...]
Arizona Nonprofit Launches First-Ever Electric Vehicle Fundraiser Featuring the Iconic Volkswagen ID. Buzz
17/07/2026
Family-focused campaign combines innovation, practicality, and purpose to help fund clinical trials for childhood blindness GILBERT, Ariz., July 17, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness, the Arizona-based [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
WALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07/2026
Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertib SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology [...]

Pages